High-flow nasal cannulae generally should be used in hypoxemic patients.
Sponsoring Organization: American College of Physicians (ACP)Background
This is the first guideline focused solely on use of high-flow nasal cannulae (HFNC). Recommendations were based on best available evidence as well as patient values and preferences, potential risks and benefits, and cost.
Key Points
Patients with hypoxemic respiratory failure should be treated initially with HFNC as opposed to noninvasive ventilation (NIV).
Patients with postextubation hypoxemia should be treated with HFNC as opposed to conventional oxygen therapy.
Reviewing Author
DisclosuresEditorial BoardsATS Scholar
DisclosuresEditorial BoardsATS Scholar
Comment
Use of HFNC to support hypoxemic patients has increased dramatically in the past decade, but guidance on when it is the best option and when it should be a…